We provide you with 20 years of free, institutional-grade data for ORMP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ORMP. Explore the full financial landscape of ORMP stock.
| Reported Date | CIK | Ticker | Type |
|---|
Oramed Pharmaceuticals Inc(NASDAQ:ORMP) 
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, ...
The information provided in this report about ORMP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.